Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
US Army
Baxter
US Department of Justice
Mallinckrodt
Express Scripts
Federal Trade Commission
McKesson
Teva

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018012

« Back to Dashboard

NDA 018012 describes PAMELOR, which is a drug marketed by Specgx Llc and is included in two NDAs. It is available from one supplier. Additional details are available on the PAMELOR profile page.

The generic ingredient in PAMELOR is nortriptyline hydrochloride. There are eleven drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the nortriptyline hydrochloride profile page.
Summary for 018012
Tradename:PAMELOR
Applicant:Specgx Llc
Ingredient:nortriptyline hydrochloride
Patents:0
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 018012

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;ORALStrengthEQ 10MG BASE/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Moodys
US Army
Merck
Deloitte
Citi
Baxter
Argus Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.